Cornerstone Capital Management Holdings’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-108,779
| Closed | -$1.2M | – | 1367 |
|
|
2017
Q2 | $1.2M | Sell |
108,779
-105,696
| -49% | -$1.16M | 0.01% | 862 |
|
|
2017
Q1 | $2.1M | Sell |
214,475
-79,495
| -27% | -$779K | 0.02% | 714 |
|
|
2016
Q4 | $3.17M | Sell |
293,970
-122,300
| -29% | -$1.32M | 0.02% | 611 |
|
|
2016
Q3 | $4.27M | Buy |
416,270
+144,900
| +53% | +$1.48M | 0.03% | 511 |
|
|
2016
Q2 | $3.55M | Buy |
271,370
+35,500
| +15% | +$464K | 0.03% | 546 |
|
|
2016
Q1 | $2.6M | Buy |
235,870
+37,300
| +19% | +$410K | 0.02% | 656 |
|
|
2015
Q4 | $1.83M | Buy |
198,570
+48,470
| +32% | +$446K | 0.02% | 761 |
|
|
2015
Q3 | $1.04M | Buy |
150,100
+134,700
| +875% | +$935K | 0.01% | 872 |
|
|
2015
Q2 | $151K | Buy |
15,400
+14,100
| +1,085% | +$138K | ﹤0.01% | 1244 |
|
|
2015
Q1 | $12K | Buy |
+1,300
| New | +$12K | ﹤0.01% | 1356 |
|
|
2014
Q3 | – | Sell |
-13,300
| Closed | -$69K | – | 1396 |
|
|
2014
Q2 | $69K | Sell |
13,300
-6,900
| -34% | -$35.8K | ﹤0.01% | 1220 |
|
|
2014
Q1 | $92K | Sell |
20,200
-23,145
| -53% | -$105K | ﹤0.01% | 1203 |
|
|
2013
Q4 | $218K | Sell |
43,345
-14,200
| -25% | -$71.4K | ﹤0.01% | 1039 |
|
|
2013
Q3 | $292K | Sell |
57,545
-36,055
| -39% | -$183K | ﹤0.01% | 999 |
|
|
2013
Q2 | $465K | Buy |
+93,600
| New | +$465K | 0.01% | 930 |
|